drugset / Trial / NCT02495844
A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is to assess the efficacy, safety, and tolerability of the investigational drug UCB0942in adult subjects with drug-resistant focal epilepsy across multiple centers in Europe.
Timeline
- Start
- 2015-07
- Primary completion
- 2017-02
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Padsevonil | Small molecule | 100 mg | Oral |
| Subject | Padsevonil | Small molecule | 200 mg | Oral |